Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lucid Diagnostics | LUCD | Nov 12, 2024 | 1.00 | -4.76 |
Lucid Group | LCID | Nov 12, 2024 | 2.14 | -8.55 |
Lufax ADR | LU | Nov 12, 2024 | 2.44 | -3.56 |
Lululemon Athletica | LULU | Nov 12, 2024 | 320.90 | +0.77 |
Lulus Fashion Lounge | LVLU | Nov 12, 2024 | 1.70 | +10.39 |
Lumen Technologies | LUMN | Nov 12, 2024 | 9.23 | -8.79 |
Lument Finance Trust | LFT | Nov 12, 2024 | 2.45 | 0.00 |
Lument Finance Trust A Pref | LFT-A | Nov 12, 2024 | 22.82 | 0.00 |
Lumentum | LITE | Nov 12, 2024 | 86.65 | -0.08 |
Luminar Technologies A | LAZR | Nov 12, 2024 | 1.13 | +10.78 |
Lumos Pharma | LUMO | Nov 12, 2024 | 4.36 | -0.23 |
Luna Innovations | LUNA | Nov 12, 2024 | 1.59 | -1.24 |
Luokung Technology | LKCO | Nov 12, 2024 | 1.70 | -3.95 |
Luxfer | LXFR | Nov 12, 2024 | 14.84 | -1.00 |
LuxUrban Hotels | LUXH | Nov 12, 2024 | 0.04 | +2.99 |
Luxurban Hotels Pref | LUXHP | Nov 12, 2024 | 16.28 | -1.69 |
Lxp Industrial Trust | LXP | Nov 12, 2024 | 9.50 | -1.45 |
LXP Industrial Trust C Pref | LXP-C | Nov 12, 2024 | 51.53 | -0.89 |
Lyell Immunopharma | LYEL | Nov 12, 2024 | 1.17 | -3.72 |
Lyft A | LYFT | Nov 12, 2024 | 18.34 | -1.34 |
LyondellBasell Industries Nv A | LYB | Nov 12, 2024 | 83.60 | -1.61 |
Lyra Therapeutics | LYRA | Nov 12, 2024 | 0.28 | +3.77 |
Lytus Technologies | LYT | Nov 12, 2024 | 1.77 | +3.51 |
M&T Bank | MTB | Nov 12, 2024 | 213.23 | -0.66 |
M&T Bank ADR Prej J | MTB-J | Nov 12, 2024 | 27.55 | -0.40 |
M&T Bank H Pref | MTB-H | Nov 12, 2024 | 25.20 | -1.68 |
M-tron Industries | MPTI | Nov 12, 2024 | 54.40 | -1.68 |
M/I Homes | MHO | Nov 12, 2024 | 156.00 | -6.06 |
M3-Brigade Acquisition V | MBAV | Nov 12, 2024 | 10.03 | 0.00 |
M3-Brigade Acquisition V | MBAVU | Nov 12, 2024 | 10.09 | -0.79 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.